Hui Ling Wu from Norwich, CT, age 55

Hui Ying Wu, New York Agent

view source

Specialties:

Residential sales
Luxury homes
First time home buyers
Relocation
Property Management
Co-op

Work:

Nest Seekers I N T E R N A T I O N A L
(646)6848699 (Phone)

Client type:

Home Buyers
Home Sellers

Property type:

Condo/Townhome
Multi-family
Co-op

Hui Wu

view source

Specialties:

Internal Medicine

Work:

Sutter Gould Medical GroupSutter Gould Medical Foundation Hospitalists
600 Coffee Rd, Modesto, CA 95355
(209)5241211 (phone), (209)5697778 (fax)

Education:

Medical School
Shanghai Second Med Univ, Shanghai City, Shanghai, China
Graduated: 1999

Languages:

English

Description:

Dr. Wu graduated from the Shanghai Second Med Univ, Shanghai City, Shanghai, China in 1999. She works in Modesto, CA and specializes in Internal Medicine. Dr. Wu is affiliated with Memorial Medical Center.

Hui Wu

view source

Us Patents

Raf Inhibitors And Their Uses
view source
US Patent:

7501430, Mar 10, 2009
Filed:

Apr 16, 2007
Appl. No.:

11/785163
Inventors:

Jean-Marc Lapierre - Pelham NH, US
Nivedita D. Namdev - Westford MA, US
Mark A. Ashwell - Carlisle MA, US
Dennis S. France - Carlisle MA, US
Hui Wu - Malden MA, US
Patrick M. Hutchins - Denver CO, US
Manish Tandon - Framingham MA, US
Yanbin Liu - Acton MA, US
Jeff S. Link - Londonderry NH, US
Syed M. Ali - North Andover MA, US
Chris J. Brassard - Somerville MA, US
Robb B. Nicewonger - Tyngsboro MA, US
Anton Filikov - Stoneham MA, US
Rebecca J. Carazza - Winchester MA, US
Assignee:

ArQule, Inc. - Woburn MA
International Classification:

C07D 498/04
C07D 513/04
A61K 31/429
A61K 31/4188
US Classification:

514275, 544333
Abstract:

The present invention provides imidazooxazole and imidazothiazole compounds and their synthesis. The compounds of the present invention are capable of inhibiting the activity of RAF kinase, such as B-RAF. The compounds are useful for the treatment of cell proliferative disorders such as cancer.

Substituted 5,6-Dihydro-6-Phenylbenzo[F]Isoquinolin-2-Amine Compounds
view source
US Patent:

8357694, Jan 22, 2013
Filed:

Dec 30, 2009
Appl. No.:

12/649573
Inventors:

Syed Ali - North Andover MA, US
Mark Ashwell - Carlisle MA, US
Manish Tandon - Framingham MA, US
Nivedita Namdev - Westford MA, US
Jean-Marc Lapierre - Pelham NH, US
Neil Westlund - Groton MA, US
Rocio Palma - North Andover MA, US
Yanbin Liu - Acton MA, US
David Vensel - Boston MA, US
Sudharshan Eathiraj - North Andover MA, US
Hui Wu - Malden MA, US
Eugene Kelleher - Wellesley MA, US
Assignee:

ArQule, Inc. - Woburn MA
International Classification:

A01N 43/54
A61K 31/505
C07D 239/00
C07D 239/70
C07D 487/00
US Classification:

514267, 544249
Abstract:

The present invention relates to substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Substituted Benzo-Pyrido-Triazolo-Diazepine Compounds
view source
US Patent:

8541407, Sep 24, 2013
Filed:

Mar 31, 2011
Appl. No.:

13/076695
Inventors:

Syed M. Ali - North Andover MA, US
Mark A. Ashwell - Carlisle MA, US
Eugene Kelleher - Wellesley MA, US
Steffi Koerner - Medford MA, US
Jean-Marc Lapierre - Pelham NH, US
Jeffrey S. Link - Londonderry NH, US
Yanbin Liu - Acton MA, US
Magdi Moussa - Malden MA, US
Rocio Palma - North Andover MA, US
Manish Tandon - Framingham MA, US
David Vensel - Boston MA, US
Neil Westlund - Groton MA, US
Hui Wu - Malden MA, US
Assignee:

ArQule, Inc. - Woburn MA
International Classification:

C07D 487/14
US Classification:

514219, 540555
Abstract:

The present invention relates to substituted benzo-pyrido-triazolo-diazepine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted benzo-pyrido-triazolo-diazepine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds or pharmaceutical compositions to subjects in need thereof.

Substituted Heterocyclic Compounds
view source
US Patent:

8563567, Oct 22, 2013
Filed:

Dec 29, 2010
Appl. No.:

12/981095
Inventors:

Syed M. Ali - North Andover MA, US
Mark A. Ashwell - Carlisle MA, US
Yanbin Liu - Acton MA, US
Magdi Moussa - Malden MA, US
Jianqiang Wang - Acton WA, US
Hui Wu - Malden MA, US
Assignee:

ArQule, Inc. - Woburn MA
International Classification:

A61K 31/505
A61K 31/44
C07D 401/04
C07D 413/04
C07D 453/06
US Classification:

514275, 514294, 544331, 546 94
Abstract:

The present invention relates to substituted heterocyclic compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted heterocyclic compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Substituted Pyrrolo-Aminopyrimidine Compounds
view source
US Patent:

8580803, Nov 12, 2013
Filed:

Dec 29, 2010
Appl. No.:

12/981138
Inventors:

Yanbin Liu - Acton MA, US
Nivedita Namdev - Westford MA, US
Rocio Palma - North Andover MA, US
Manish Tandon - Framingham MA, US
Jianqiang Wang - Acton MA, US
Hui Wu - Malden MA, US
Assignee:

ArQule, Inc. - Woburn MA
International Classification:

C07D 487/04
A61K 31/519
A61P 35/00
A61P 25/28
A61P 29/00
US Classification:

5142651
Abstract:

The present invention relates to substituted pyrrolo-aminopyrimidine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted pyrrolo-aminopyrimidine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof. The substituted pyrrolo-aminopyrimidine compounds have the following general formula:.

Raf Inhibitors And Uses Thereof
view source
US Patent:

20090136499, May 28, 2009
Filed:

Jan 20, 2009
Appl. No.:

12/356097
Inventors:

Jean-Marc Lapierre - Pelham NH, US
Nivedita D. Namdev - Westford MA, US
Mark A. Ashwell - Carlisle MA, US
Dennis S. France - Cambridge MA, US
Hui Wu - Malden MA, US
Patrick M. Hutchins - Denver CO, US
Manish Tandon - Framingham MA, US
Yanbin Liu - Acton MA, US
Jeff S. Link - Londonderry NH, US
Syed M. Ali - North Andover MA, US
Chris J. Brassard - Somerville MA, US
Robb B. Nicewonger - Tyngsboro MA, US
Anton Filikov - Stoneham MA, US
Rebecca J. Carazza - Winchester MA, US
Assignee:

ARQULE, INC. - Woburn MA
International Classification:

A61K 39/395
C07D 513/04
A61K 31/506
A61K 31/5377
C07D 498/04
A61P 35/00
US Classification:

4241331, 544331, 514275, 5142332, 544122, 51421021
Abstract:

The present invention provides imidazooxazole and imidazothiazole compounds and their synthesis. The compounds of the present invention are capable of inhibiting the activity of RAF kinase, such as B-RAF. The compounds are useful for the treatment of cell proliferative disorders such as cancer.

Hdac Inhibitors
view source
US Patent:

20100261710, Oct 14, 2010
Filed:

Aug 21, 2008
Appl. No.:

12/671351
Inventors:

Mark A. Ashwell - Carlisle MA, US
Manish Tandon - Framingham MA, US
Nivedita D. Namdev - Westford MA, US
Jean-Marc Lapierre - Pelham NH, US
Yanbin Liu - Acton MA, US
Hui Wu - Malden MA, US
Assignee:

ARQULE, INC. - Woburn MA
International Classification:

A61K 31/5517
C07D 487/12
C07D 455/06
A61K 31/437
A61K 31/425
C07D 513/04
A61P 35/04
US Classification:

514220, 540561, 546 95, 514294, 514368, 548154
Abstract:

The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.

Article Comprising A Superconducting Rf Filter
view source
US Patent:

61147583, Sep 5, 2000
Filed:

Aug 21, 1998
Appl. No.:

9/138102
Inventors:

Alfredo Carlos Anderson - Watertown MA
Zhengxiang Ma - New Providence NJ
Paul Anthony Polakos - Marlboro NJ
Hui Wu - North Plainfield NJ
Assignee:

Lucent Technologies Inc. - Murray Hill NJ
Massachusetts Inst. of Technology - Cambridge MA
International Classification:

H01L 2302
H01L 2352
H01L 2310
US Classification:

257686
Abstract:

The disclosed superconducting multipole RF filter comprises a multiplicity of coupled circular disk resonators designed for operation in the TM 010 mode. The disk resonators are arranged in a co-axial stack, with a circular metal spacer sandwiched between any two neighboring disk resonators. Each metal spacer has a central through-aperture, with a conductive member disposed in the through-aperture and electrically connecting the two neighboring disk resonators that are sandwiching a given metal spacer. A disk resonator comprises two circular members, each circular member comprising a circular dielectric substrate, exemplarily a LaAlO. sub. 3 wafer. Superconducting layers (typically YBCO) are disposed on each major surface of the substrate. The two members are joined together such that conductive layers (typically gold) electrically connect the two outside superconducting layers. The disclosed RF filter has good power handling capability, is compact, has good heat removal and relatively simple tuning.